Literature DB >> 5347550

Influence of dextran upon renal blood flow in normovolemic and hypovolemic animals treated with adrenergic blocking agents.

F E Wideman, H B Shumacker, T M Minor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5347550      PMCID: PMC1387649          DOI: 10.1097/00000658-196911000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  THE NATURE OF IRREVERSIBLE SHOCK: EXPERIMENTAL AND CLINICAL OBSERVATIONS.

Authors:  R C LILLEHEI; J K LONGERBEAM; J H BLOCH; W G MANAX
Journal:  Ann Surg       Date:  1964-10       Impact factor: 12.969

2.  CONTROLLED HYPOTENSION IN THE MANAGEMENT OF SEVERE HEMORRHAGE.

Authors:  R W HOPKINS; R FRATIANNE; I PENN; G SABGA; F A SIMEONE
Journal:  Ann Surg       Date:  1964-10       Impact factor: 12.969

3.  PLASMA CATECHOLAMINES IN OPEN-HEART SURGERY; PREVENTION OF THEIR PERNICIOUS EFFECTS BY PRETREATMENT WITH DIBENZYLINE.

Authors:  R C LILLEHEI; C W LILLEHEI; J T GRISMER; M J LEVY
Journal:  Surg Forum       Date:  1963

4.  An experimental study of arfonad in hemorrhagic shock in dogs.

Authors:  J G CONVERSE; A BOBA
Journal:  Am Surg       Date:  1957-05       Impact factor: 0.688

5.  Ganglionic blockade and its protective action in hemorrhage; a review.

Authors:  A BOBA; J G CONVERSE
Journal:  Anesthesiology       Date:  1957 Jul-Aug       Impact factor: 7.892

6.  Use of controlled hypotension in large blood vessel surgery.

Authors:  W W GLENN; L J HAMPTON; A V GOODYER
Journal:  AMA Arch Surg       Date:  1954-01

7.  Effects of adrenergic blocking agents on renal blood flow in normovolemia and experimental hypovolemia.

Authors:  H Y Muhm; H B Shumacker
Journal:  Ann Surg       Date:  1966-07       Impact factor: 12.969

  7 in total
  1 in total

1.  Prophylactic diuresis with ethacrynic acid for prevention of postoperative renal failure.

Authors:  W M Stahl; A M Stone
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.